SELENON (SEPN1) に関連した二次性低呼吸症による重度の阻害性睡眠時無呼吸症の管理に関する回復力物語
Raghad Alhajaji1, Hamza O Dhafar2, Muslim Mohammed Al Saadi3
1Sleep Medicine Fellowship King Saud University Medical City Riyadh Saudi Arabia.
Respirology case reports
|August 29, 2025
まとめ
SELENONに関連した筋痛症の患者は,重度の呼吸障害を経験することがあります. 15歳の男性の呼吸器の合併症を効果的に管理し,酸素飽和度を正常化しました.
科学分野:
- 神経科学
- 肺科
- 遺伝学
背景:
- SELENONに関連したミオパシーは,筋肉の弱さを引き起こす珍しい自己相性後退性疾患です.
- 睡眠障害と呼吸不全は一般的な合併症です.
- 漸進的な呼吸器障害は 高度な管理戦略を必要とします
研究 の 目的:
- 遺伝的に確認されたSELENON関連ミオパシーの患者の呼吸管理について説明します.
- SELENONに関連したミオパシーにおける睡眠呼吸障害の進化を説明します.
- 複合呼吸器不全の管理において,体積標的圧力サポート (VtPS) の陽性空気圧 (PAP) の有効性を評価する.
主な方法:
- SELENONに関連する 筋痛症の15歳の男性の症例報告
- 睡眠障害の呼吸を評価するための縦断型ポリソムノグラフィー (PSG)
- 自発的タイムモード (BPAP-ST) の2レベルの陽気気圧による管理と,補足酸素によるVtPS PAPへの移行.
主要な成果:
- 患者は12年間 進行性の睡眠関連の呼吸障害を呈していた.
- BPAP- STによる初期治療では,アプネア/ヒポネアが除去されたが,レム睡眠の不飽和が持続した.
- VtPS PAPへの移行 酸素の飽和度が正常化し,呼吸器のイベントが廃止されました.
結論:
- SELENONに関連した筋痛は,呼吸器管理に重大な課題をもたらします.
- 酸素と組み合わせたVtPSの夜間PAPは,SELENON-RMにおける低換気と不飽和の有効な戦略です.
- このアプローチは全ての睡眠段階において 呼吸器のパラメータを正常化し 患者の治療結果を改善しました
関連する概念動画
01:21Sleep Apnea
220
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
220
01:30Acute Respiratory Failure-III
316
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
316
01:17Other Pulmonary Disorders
905
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
905
01:25Hyperpnea and Hyperventilation
1.3K
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
1.3K
01:23Physiological Control of Respiration
3.2K
Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
3.2K
01:22Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27